Table 4 Factors associated with PHQ-4 categories or suggestive scores on FiRST

Male

14

(37.8)

13

(59.1)

5

(55.6)

24

(64.8)

0.119

35

(47.3)

21

(67.7)

0.055

Age (years)

Mean (SD)

46.8 (13.3)

45.7 (13.3)

41.2 (13.9)

45.4 (12.2)

0.715

44.8 (13.4)

47.8 (11.8)

0.303

Nail Psoriasis

20

(54.1)

11

(50)

7

(77.8)

19

(51.4)

0.514

40

(50.1)

17

(54.8)

0.941

Polyarthritis

28

(75.7)

20

(90.9)

9

(100)

27

(73.0)

0.141

54

(73.0)

30

(96.8)

0.005

Axial involvement

11

(29.7)

10

(45.5)

4

(44.4)

12

(32.4)

0.581

25

(33.8)

12

(38.7)

0.630

Enthesitis

5

(13.5)

9

(40.9)

2

(22.4)

11

(29.7)

0.116

14

(18.9)

13

(42.9)

0.014

Dactylitis

13

(35.1)

8

(36.4)

6

(66.7)

4

(10.8)

0.004

19

(25.7)

12

(38.7)

0.182

Methotrexate

20

(54.1)

6

(27.3)

7

(77.8)

20

(54.1)

0.049

37

(50)

16

(51.6)

0.880

Sulfasalazine

10

27.0

4

(18.2)

1

(11.1)

13

(35.1)

0.264

21

(28.4)

7

(22.6)

0.348

Anti-TNF

9

(24.3)

6

(27.3)

1

(11.1)

5

(13.5)

0.462

16

(21.6)

5

(16.1)

0.521

PsAID-12

Mean (SD)

2.51 (1.56)

6.04 (1.92)

7.52 (1.61)

4.97 (1.93)

< 0.001

3.68 (2.15)

6.61 (1.70)

< 0.001

DAPSA

Mean (SD)

24.1 (20.5)

49.5 (53.1)

42.6 (16.3)

29.0 (25.6)

0.025

29.7 (35.9)

41.1 (23.1)

0.120

HAQ

Mean (SD)

0.50 (0.51)

1.24 (0.589)

1.47 (0.63)

0.84 (0.53)

< 0.001

0.68 (0.59)

1.29 (0.51))

< 0.001

ESR

Mean (SD)

25.1 (22.9)

42.4 (30.0)

24.6 (10.5)

35.3 (24.2)

0.044

31.9 (26.2)

33.5 (22.3)

0.766

CRP

Mean (SD)

7.86 (11.0)

18.8 (36.3)

4.06 (3.68)

9.81 (21.0)

0.214

11.9 (25.2)

7.12 (10.7)

0.308